Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

To be or not to be pink(1): contradictory findings in an animal model for Parkinson's disease.

de Haas R, Heltzel LCMW, Tax D, van den Broek P, Steenbreker H, Verheij MMM, Russel FGM, Orr AL, Nakamura K, Smeitink JAM.

Brain Commun. 2019;1(1):fcz016. doi: 10.1093/braincomms/fcz016. Epub 2019 Sep 13.

2.

The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ; MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium.

Eur J Cancer. 2019 Nov;122:42-52. doi: 10.1016/j.ejca.2019.07.021. Epub 2019 Oct 12. Review.

PMID:
31614288
3.

Deletion of the serotonin transporter perturbs BDNF signaling in the central amygdala following long-access cocaine self-administration.

Caffino L, Mottarlini F, Diniz DM, Verheij MM, Fumagalli F, Homberg JR.

Drug Alcohol Depend. 2019 Oct 6;205:107610. doi: 10.1016/j.drugalcdep.2019.107610. [Epub ahead of print]

PMID:
31606593
4.

Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial.

Elbers JBW, Al-Mamgani A, Tesseslaar MET, van den Brekel MWM, Lange CAH, van der Wal JE, Verheij M, Zuur CL, de Boer JP.

Radiother Oncol. 2019 Sep 26. pii: S0167-8140(19)33046-4. doi: 10.1016/j.radonc.2019.08.007. [Epub ahead of print]

PMID:
31563412
5.

Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCC.

Essers PBM, van der Heijden M, Verhagen CVM, Ploeg EM, de Roest RH, Leemans CR, Brakenhoff RH, van den Brekel MWM, Bartelink H, Verheij M, Vens C.

Cancer Res. 2019 Nov 1;79(21):5597-5611. doi: 10.1158/0008-5472.CAN-18-3388. Epub 2019 Sep 12.

PMID:
31515237
6.

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib.

de Haan R, van Werkhoven E, van den Heuvel MM, Peulen HMU, Sonke GS, Elkhuizen P, van den Brekel MWM, Tesselaar MET, Vens C, Schellens JHM, van Triest B, Verheij M.

BMC Cancer. 2019 Sep 10;19(1):901. doi: 10.1186/s12885-019-6121-3.

7.

Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial.

Lambrecht ML, Eaton DJ, Sonke JJ, Nestle U, Peulen H, Weber DC, Verheij M, Hurkmans CW.

Radiother Oncol. 2019 Sep;138:106-113. doi: 10.1016/j.radonc.2019.06.008. Epub 2019 Jun 25.

PMID:
31252291
8.

Micro cone beam computed tomography for sensitive assessment of radiation-induced late lung toxicity in preclinical models.

van Berlo D, Khmelinskii A, Gasparini A, Salguero FJ, Floot B, de Wit N, van de Ven M, Song JY, Coppes RP, Verheij M, Sonke JJ, Vens C.

Radiother Oncol. 2019 Sep;138:17-24. doi: 10.1016/j.radonc.2019.05.007. Epub 2019 May 27.

PMID:
31146069
9.

Genome-wide cell-free DNA fragmentation in patients with cancer.

Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen SØ, Medina JE, Hruban C, White JR, Palsgrove DN, Niknafs N, Anagnostou V, Forde P, Naidoo J, Marrone K, Brahmer J, Woodward BD, Husain H, van Rooijen KL, Ørntoft MW, Madsen AH, van de Velde CJH, Verheij M, Cats A, Punt CJA, Vink GR, van Grieken NCT, Koopman M, Fijneman RJA, Johansen JS, Nielsen HJ, Meijer GA, Andersen CL, Scharpf RB, Velculescu VE.

Nature. 2019 Jun;570(7761):385-389. doi: 10.1038/s41586-019-1272-6. Epub 2019 May 29.

PMID:
31142840
10.

Impaired Fear Extinction Recall in Serotonin Transporter Knockout Rats Is Transiently Alleviated during Adolescence.

Schipper P, Brivio P, de Leest D, Madder L, Asrar B, Rebuglio F, Verheij MMM, Kozicz T, Riva MA, Calabrese F, Henckens MJAG, Homberg JR.

Brain Sci. 2019 May 22;9(5). pii: E118. doi: 10.3390/brainsci9050118.

11.

Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients.

van der Heijden M, de Jong MC, Verhagen CVM, de Roest RH, Sanduleanu S, Hoebers F, Leemans CR, Brakenhoff RH, Vens C, Verheij M, van den Brekel MWM.

Cancers (Basel). 2019 Apr 25;11(4). pii: E583. doi: 10.3390/cancers11040583.

12.

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy.

Vossen DM, Verhagen CVM, van der Heijden M, Essers PBM, Bartelink H, Verheij M, Wessels LFA, van den Brekel MWM, Vens C.

Cancers (Basel). 2019 Mar 29;11(4). pii: E445. doi: 10.3390/cancers11040445.

13.

Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.

Hamming-Vrieze O, Depauw N, Craft DL, Chan AW, Rasch CRN, Verheij M, Sonke JJ, Kooy HM.

Phys Med Biol. 2019 Apr 23;64(9):095001. doi: 10.1088/1361-6560/ab1459.

PMID:
30921775
14.

The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.

Lutz MP, Zalcberg JR, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch HI, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, Röcken C, Roviello F, Schneider PM, Seewald S, Smyth E, van Cutsem E, Verheij M, Wagner AD, Otto F.

Eur J Cancer. 2019 May;112:1-8. doi: 10.1016/j.ejca.2019.01.106. Epub 2019 Mar 15. Review.

PMID:
30878666
15.

Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results.

Lambrecht M, Clementel E, Sonke JJ, Nestle U, Adebahr S, Guckenberger M, Andratschke N, Weber DC, Verheij M, Hurkmans CW.

Radiother Oncol. 2019 Mar;132:63-69. doi: 10.1016/j.radonc.2018.10.025. Epub 2018 Dec 21.

PMID:
30825971
16.

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer.

Vollenbrock SE, Voncken FEM, van Dieren JM, Lambregts DMJ, Maas M, Meijer GJ, Goense L, Mook S, Hartemink KJ, Snaebjornsson P, Ter Beek LC, Verheij M, Aleman BMP, Beets-Tan RGH, Bartels-Rutten A.

Br J Surg. 2019 Apr;106(5):596-605. doi: 10.1002/bjs.11094. Epub 2019 Feb 25.

17.

Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

Borggreve AS, Goense L, Brenkman HJF, Mook S, Meijer GJ, Wessels FJ, Verheij M, Jansen EPM, van Hillegersberg R, van Rossum PSN, Ruurda JP.

Br J Radiol. 2019 May;92(1097):20181044. doi: 10.1259/bjr.20181044. Epub 2019 Mar 5. Review.

PMID:
30789792
18.

Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity.

Kroon P, Frijlink E, Iglesias-Guimarais V, Volkov A, van Buuren MM, Schumacher TN, Verheij M, Borst J, Verbrugge I.

Cancer Immunol Res. 2019 Apr;7(4):670-682. doi: 10.1158/2326-6066.CIR-18-0654. Epub 2019 Feb 19.

PMID:
30782666
19.

Ultrahigh-resolution MRI reveals structural brain differences in serotonin transporter knockout rats after sucrose and cocaine self-administration.

Karel P, Van der Toorn A, Vanderschuren L, Guo C, Sadighi Alvandi M, Reneman L, Dijkhuizen R, Verheij MMM, Homberg JR.

Addict Biol. 2019 Feb 12. doi: 10.1111/adb.12722. [Epub ahead of print]

PMID:
30748070
20.

Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.

Elbers JBW, Veldhuis LI, Bhairosing PA, Smeele LE, Jóźwiak K, van den Brekel MWM, Verheij M, Al-Mamgani A, Zuur CL.

Eur Arch Otorhinolaryngol. 2019 Mar;276(3):647-655. doi: 10.1007/s00405-019-05292-0. Epub 2019 Jan 23.

PMID:
30673847
21.

Age-related distribution and dynamics of T-cells in blood and lymphoid tissues of goats.

Baliu-Piqué M, Kurniawan H, Ravesloot L, Verheij MW, Drylewicz J, Lievaart-Peterson K, Borghans JAM, Koets A, Tesselaar K.

Dev Comp Immunol. 2019 Apr;93:1-10. doi: 10.1016/j.dci.2018.12.004. Epub 2018 Dec 11.

PMID:
30550777
22.

Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Elbers JBW, Al-Mamgani A, van den Brekel MWM, Jóźwiak K, de Boer JP, Lohuis PJFM, Willems SM, Verheij M, Zuur CL.

Otolaryngol Head Neck Surg. 2019 Jun;160(6):1023-1033. doi: 10.1177/0194599818818443. Epub 2018 Dec 11.

PMID:
30526317
23.

Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association.

Vossen DM, Verhagen CVM, Grénman R, Kluin RJC, Verheij M, van den Brekel MWM, Wessels LFA, Vens C.

PLoS One. 2018 Nov 8;13(11):e0206632. doi: 10.1371/journal.pone.0206632. eCollection 2018.

24.

Tumour deposits are a significant prognostic factor in gastric cancer - a systematic review and meta-analysis.

Graham Martínez C, Knijn N, Verheij M, Nagtegaal ID, van der Post RS.

Histopathology. 2019 May;74(6):809-816. doi: 10.1111/his.13781. Epub 2019 Feb 10.

PMID:
30376189
25.

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.

Borggreve AS, Mook S, Verheij M, Mul VEM, Bergman JJ, Bartels-Rutten A, Ter Beek LC, Beets-Tan RGH, Bennink RJ, van Berge Henegouwen MI, Brosens LAA, Defize IL, van Dieren JM, Dijkstra H, van Hillegersberg R, Hulshof MC, van Laarhoven HWM, Lam MGEH, van Lier ALHMW, Muijs CT, Nagengast WB, Nederveen AJ, Noordzij W, Plukker JTM, van Rossum PSN, Ruurda JP, van Sandick JW, Weusten BLAM, Voncken FEM, Yakar D, Meijer GJ; PRIDE study group.

BMC Cancer. 2018 Oct 20;18(1):1006. doi: 10.1186/s12885-018-4892-6.

26.

Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue Sarcomas.

Lansu J, Groenewegen J, van Coevorden F, van Houdt W, van Akkooi ACJ, van Boven H, van de Sande M, Verheij M, Haas RL.

Eur J Surg Oncol. 2019 Apr;45(4):684-690. doi: 10.1016/j.ejso.2018.09.001. Epub 2018 Oct 6.

PMID:
30316565
27.

Short Lifespans of Memory T-cells in Bone Marrow, Blood, and Lymph Nodes Suggest That T-cell Memory Is Maintained by Continuous Self-Renewal of Recirculating Cells.

Baliu-Piqué M, Verheij MW, Drylewicz J, Ravesloot L, de Boer RJ, Koets A, Tesselaar K, Borghans JAM.

Front Immunol. 2018 Sep 11;9:2054. doi: 10.3389/fimmu.2018.02054. eCollection 2018.

28.

Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial.

Claassen YHM, Hartgrink HH, de Steur WO, Dikken JL, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Kranenbarg WMM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Gastric Cancer. 2019 Mar;22(2):369-376. doi: 10.1007/s10120-018-0875-1. Epub 2018 Sep 20.

29.

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.

Slagter AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, van Grieken NCT, Sikorska K, Cats A, Muller-Timmermans P, Hulshof MCCM, Boot H, Los M, Beerepoot LV, Peters FPJ, Hospers GAP, van Etten B, Hartgrink HH, van Berge Henegouwen MI, Nieuwenhuijzen GAP, van Hillegersberg R, van der Peet DL, Grabsch HI, Verheij M.

BMC Cancer. 2018 Sep 10;18(1):877. doi: 10.1186/s12885-018-4770-2.

30.

Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review.

Huizing DMV, de Wit-van der Veen BJ, Verheij M, Stokkel MPM.

EJNMMI Res. 2018 Aug 29;8(1):89. doi: 10.1186/s13550-018-0443-z. Review.

31.

Increased cocaine self-administration in rats lacking the serotonin transporter: a role for glutamatergic signaling in the habenula.

Caffino L, Verheij MMM, Que L, Guo C, Homberg JR, Fumagalli F.

Addict Biol. 2019 Nov;24(6):1167-1178. doi: 10.1111/adb.12673. Epub 2018 Aug 24.

PMID:
30144237
32.

Adjuvant therapy in resectable gastric cancer-the CRITICS trial - Authors' reply.

Cats A, Sikorska K, Verheij M.

Lancet Oncol. 2018 Jul;19(7):e331. doi: 10.1016/S1470-2045(18)30436-4. Epub 2018 Jun 29. No abstract available.

PMID:
30084374
33.

The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT).

Navran A, Heemsbergen W, Janssen T, Hamming-Vrieze O, Jonker M, Zuur C, Verheij M, Remeijer P, Sonke JJ, van den Brekel M, Al-Mamgani A.

Radiother Oncol. 2019 Jan;130:25-31. doi: 10.1016/j.radonc.2018.06.032. Epub 2018 Jul 10.

PMID:
30005953
34.

Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results from the CRITICS Trial.

Claassen YHM, van Amelsfoort RM, Hartgrink HH, Dikken JL, de Steur WO, van Sandick JW, van Grieken NCT, Cats A, Boot H, Trip AK, Jansen EPM, Kranenbarg EM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002940. [Epub ahead of print]

PMID:
29995679
35.

Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.

Vossen DM, Verhagen CVM, Verheij M, Wessels LFA, Vens C, van den Brekel MWM.

Oral Oncol. 2018 Jun;81:35-44. doi: 10.1016/j.oraloncology.2018.04.006. Epub 2018 Apr 13.

PMID:
29884412
36.

Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma.

Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C.

Oncotarget. 2018 Apr 6;9(26):18198-18213. doi: 10.18632/oncotarget.24797. eCollection 2018 Apr 6.

37.

Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.

Claassen YHM, van Sandick JW, Hartgrink HH, Dikken JL, De Steur WO, van Grieken NCT, Boot H, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Br J Surg. 2018 May;105(6):728-735. doi: 10.1002/bjs.10773.

PMID:
29652082
38.

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

Cats A, Jansen EPM, van Grieken NCT, Sikorska K, Lind P, Nordsmark M, Meershoek-Klein Kranenbarg E, Boot H, Trip AK, Swellengrebel HAM, van Laarhoven HWM, Putter H, van Sandick JW, van Berge Henegouwen MI, Hartgrink HH, van Tinteren H, van de Velde CJH, Verheij M; CRITICS investigators.

Lancet Oncol. 2018 May;19(5):616-628. doi: 10.1016/S1470-2045(18)30132-3. Epub 2018 Apr 9.

PMID:
29650363
39.

Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.

Claassen YHM, Hartgrink HH, Dikken JL, de Steur WO, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Eur J Surg Oncol. 2018 May;44(5):613-619. doi: 10.1016/j.ejso.2018.02.004. Epub 2018 Feb 9.

PMID:
29503129
40.

Median and Dorsal Raphe Serotonergic Neurons Control Moderate Versus Compulsive Cocaine Intake.

Verheij MMM, Contet C, Karel P, Latour J, van der Doelen RHA, Geenen B, van Hulten JA, Meyer F, Kozicz T, George O, Koob GF, Homberg JR.

Biol Psychiatry. 2018 Jun 15;83(12):1024-1035. doi: 10.1016/j.biopsych.2017.10.031. Epub 2017 Nov 20.

41.

Appetitive to aversive counter-conditioning as intervention to reduce reinstatement of reward-seeking behavior: the role of the serotonin transporter.

Karel P, Almacellas-Barbanoj A, Prijn J, Kaag AM, Reneman L, Verheij MMM, Homberg JR.

Addict Biol. 2019 May;24(3):344-354. doi: 10.1111/adb.12596. Epub 2018 Jan 2.

PMID:
29292566
42.

Radiation Oncology in The Netherlands.

Slotman BJ, Vos P, Slot A, Keus R, Verheij M.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):5-11. doi: 10.1016/j.ijrobp.2017.09.005. No abstract available.

PMID:
29254780
43.

Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.

Elbers JBW, Al-Mamgani A, Paping D, van den Brekel MWM, Jóźwiak K, de Boer JP, Karakullukcu B, Verheij M, Zuur CL.

Oral Oncol. 2017 Dec;75:163-168. doi: 10.1016/j.oraloncology.2017.11.006.

PMID:
29224815
44.

Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases.

Kwint M, Walraven I, Burgers S, Hartemink K, Klomp H, Knegjens J, Verheij M, Belderbos J.

Lung Cancer. 2017 Oct;112:134-139. doi: 10.1016/j.lungcan.2017.08.006. Epub 2017 Aug 12.

PMID:
29191586
45.

Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.

Borst GR, Kumareswaran R, Yücel H, Telli S, Do T, McKee T, Zafarana G, Jonkers J, Verheij M, O'Connor MJ, Rottenberg S, Bristow RG.

Oncotarget. 2017 Sep 15;8(50):87638-87646. doi: 10.18632/oncotarget.20936. eCollection 2017 Oct 20.

46.

Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials.

de Haan R, Pluim D, van Triest B, van den Heuvel M, Peulen H, van Berlo D, George J, Verheij M, Schellens JHM, Vens C.

Radiother Oncol. 2018 Mar;126(3):443-449. doi: 10.1016/j.radonc.2017.10.017. Epub 2017 Nov 14.

47.

In Reply: Centralization of Upper Gastrointestinal Cancer Care Should Be Dictated by Quality of Care.

Henneman D, Dikken JL, Putter H, Lemmens VEPP, Van der Geest LGM, van Hillegersberg R, Verheij M, van de Velde CJH, Wouters MWJM.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):621-622. doi: 10.1245/s10434-017-6222-7. Epub 2017 Nov 13. No abstract available.

PMID:
29134375
48.

Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial.

Claassen YHM, de Steur WO, Hartgrink HH, Dikken JL, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Kranenbarg WMM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Ann Surg. 2018 Dec;268(6):1008-1013. doi: 10.1097/SLA.0000000000002444.

PMID:
28817437
49.

Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift.

Al-Mamgani A, Verheij M, van den Brekel MWM.

Eur J Cancer. 2017 Sep;82:1-5. doi: 10.1016/j.ejca.2017.05.035. Epub 2017 Jun 19. Review.

PMID:
28633075
50.

R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology.

Verkooijen HM, Kerkmeijer LGW, Fuller CD, Huddart R, Faivre-Finn C, Verheij M, Mook S, Sahgal A, Hall E, Schultz C.

Front Oncol. 2017 Apr 3;7:59. doi: 10.3389/fonc.2017.00059. eCollection 2017.

Supplemental Content

Loading ...
Support Center